Works matching DE "NON-alcoholic fatty liver disease"
Results: 5000
Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It?
- Published in:
- Journal of Digestive Diseases, 2024, v. 25, n. 11/12, p. 645, doi. 10.1111/1751-2980.13329
- By:
- Publication type:
- Article
The "Chinese Approach" Towards Diagnosis and Management of Fatty Liver Diseases: Seek Common Ground While Reserving Differences.
- Published in:
- Journal of Digestive Diseases, 2024, v. 25, n. 11/12, p. 634, doi. 10.1111/1751-2980.13327
- By:
- Publication type:
- Article
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction–Associated Steatotic Liver Disease.
- Published in:
- Journal of Digestive Diseases, 2024, v. 25, n. 11/12, p. 685, doi. 10.1111/1751-2980.13325
- By:
- Publication type:
- Article
Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2024, v. 19, n. 4, p. 335, doi. 10.1080/17446651.2024.2365791
- By:
- Publication type:
- Article
The pathophysiology of MASLD: an immunometabolic perspective.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 4, p. 375, doi. 10.1080/1744666X.2023.2294046
- By:
- Publication type:
- Article
Clinical utility of liver function tests for resolution of metabolic dysfunction‐associated steatotic liver disease after weight loss in the Diabetes Remission Clinical Trial.
- Published in:
- Diabetic Medicine, 2025, v. 42, n. 3, p. 1, doi. 10.1111/dme.15462
- By:
- Publication type:
- Article
Exposure–response modeling of liver fat imaging endpoints in non‐alcoholic fatty liver disease populations administered ervogastat alone and co‐administered with clesacostat.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 2, p. 317, doi. 10.1002/psp4.13275
- By:
- Publication type:
- Article
Legumes as a Substitute for Red and Processed Meat, Poultry or Fish, and the Risk of Non‐Alcoholic Fatty Liver Disease in a Large Cohort.
- Published in:
- Journal of Human Nutrition & Dietetics, 2025, v. 38, n. 1, p. 1, doi. 10.1111/jhn.70004
- By:
- Publication type:
- Article
Haloacetamides exacerbate non-alcoholic fatty liver disease induced by a high-fat diet in C57BL/6J mice.
- Published in:
- Toxicological Sciences, 2025, v. 204, n. 1, p. 57, doi. 10.1093/toxsci/kfae160
- By:
- Publication type:
- Article
Reliability of an Expanded Non-alcoholic Steatohepatitis Grading and Staging System for Assessment of Disease Activity and Fibrosis.
- Published in:
- International Journal of Surgical Pathology, 2025, v. 33, n. 2, p. 281, doi. 10.1177/10668969241260226
- By:
- Publication type:
- Article
Biochemical, sex hormonal, and anthropometric predictors of non-alcoholic fatty liver disease in polycystic ovary syndrome.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03648-9
- By:
- Publication type:
- Article
Non-Alkolik Yağlı Karaciğer Hastalığı Olan Hastalarda Fibrozis Puanlarının Atriyal Fibrilasyon Yükünü Yansıtmadaki Başarısı.
- Published in:
- MN Cardiology / MN Kardiyoloji, 2025, v. 32, n. 1, p. 1
- By:
- Publication type:
- Article
Development and Validation of AAV-Mediated Liver, Liver-VAT, and Liver-Brain SORT and Therapeutic Regulation of FASN in Hepatic De Novo Lipogenesis.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 5, p. 372, doi. 10.3390/cells14050372
- By:
- Publication type:
- Article
The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017–2020.
- Published in:
- BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-025-03756-8
- By:
- Publication type:
- Article
Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-90818-2
- By:
- Publication type:
- Article
Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease.
- Published in:
- Nutrition & Metabolism, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12986-025-00899-z
- By:
- Publication type:
- Article
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS.
- Published in:
- Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06220-z
- By:
- Publication type:
- Article
Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort.
- Published in:
- BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-025-03738-w
- By:
- Publication type:
- Article
Fructose intake in patients with non-alcoholic fatty liver disease.
- Published in:
- Proceedings of Singapore Healthcare, 2019, v. 28, n. 4, p. 218, doi. 10.1177/2010105819840370
- By:
- Publication type:
- Article
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress.
- Published in:
- Journal of Inflammation Research, 2025, v. 18, p. 601, doi. 10.2147/JIR.S497737
- By:
- Publication type:
- Article
CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02051-y
- By:
- Publication type:
- Article
Author Correction: Monocytes to Apolipoprotein A1 ratio is associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Sex differences in predicting dyslipidemia using polygenic risk score with fatty liver index and fibrotic nonalcoholic steatohepatitis index.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-92766-3
- By:
- Publication type:
- Article
A Study on Prevalence and Pattern of Nonalcoholic Fatty Liver Disease Among Patients Attending a Tertiary Care Hospital in Guntur District, A.P.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 449
- By:
- Publication type:
- Article
Study Of Non-Alcoholic Fatty Liver Disease (Nafld) In Type 2 Diabetees Mellitus.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 77
- By:
- Publication type:
- Article
Prevalence of Non-Alcoholic Fatty Liver Disease and factors associated with it among Adult Population attending a Tertiary Care Centre at Rajamahendravaram.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 465
- By:
- Publication type:
- Article
Prevalence Of Non-Alcoholic Fatty Liver Disease in Newly Diagnosed Type 2 Diabetes Mellitus.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 745
- By:
- Publication type:
- Article
Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Gastroenterology Insights, 2022, v. 13, n. 3, p. 275, doi. 10.3390/gastroent13030028
- By:
- Publication type:
- Article
The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
- Published in:
- Gastroenterology Insights, 2022, v. 13, n. 2, p. 148, doi. 10.3390/gastroent13020016
- By:
- Publication type:
- Article
Diagnostic Accuracy of Non-Invasive Diagnostic Tests for Nonalcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
- Published in:
- Clinical Epidemiology, 2025, v. 17, p. 53, doi. 10.2147/CLEP.S501445
- By:
- Publication type:
- Article
Prevalence and association of non-alcoholic fatty liver disease and insulin resistance among non-diabetic obese, overweight, and metabolically obese normal-weight adult patients attending at a tertiary care hospital in Eastern India.
- Published in:
- Asian Journal of Medical Sciences, 2025, v. 16, n. 2, p. 52, doi. 10.71152/ajms.v16i2.4341
- By:
- Publication type:
- Article
Ethanol extract of Garcinia kola seeds alleviates HGHFD/STZ-induced nonalcoholic fatty liver disease in diabetic rats by modulating oxidative stress, inflammation, and lipid accumulation.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2025, v. 28, n. 5, p. 662, doi. 10.22038/ijbms.2025.82786.17889
- By:
- Publication type:
- Article
Insights Into Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus in Somalia: Prevalence and Risk Factors.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 507, doi. 10.2147/DMSO.S486956
- By:
- Publication type:
- Article
Association of Sensitivity to Thyroid Hormones and Non-Alcoholic Fatty Liver Disease and the Severity of Liver Fibrosis in Euthyroid Adults: A Retrospective Study.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 479, doi. 10.2147/DMSO.S499517
- By:
- Publication type:
- Article
Jiangzhi Granule Ameliorates JNK-Mediated Mitochondrial Dysfunction to Reduce Lipotoxic Liver Injury in NASH.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 23, doi. 10.2147/DMSO.S492174
- By:
- Publication type:
- Article
The Log<sub>e</sub> GDR Was Strongly Associated with NAFLD as a Predictor in Normoalbuminuric Patients with Type 2 Diabetes.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 115, doi. 10.2147/DMSO.S500739
- By:
- Publication type:
- Article
Comorbidity Pattern in Patients with Moderate-to-Severe Plaque Psoriasis: Network Analysis of a Hospitalized Database in China.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2025, v. 18, p. 491, doi. 10.2147/CCID.S509739
- By:
- Publication type:
- Article
Aldose reductase, fructose and fat production in the liver.
- Published in:
- Biochemical Journal, 2025, v. 482, n. 5, p. 295, doi. 10.1042/BCJ20240748
- By:
- Publication type:
- Article
Effects of Biologics on Fibrosis-4 Index in Patients with Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2025, v. 92, n. 1, p. 88, doi. 10.1272/jnms.JNMS.2025_92-114
- By:
- Publication type:
- Article
Editorial: Metabolic associated fatty liver disease (MAFLD) in childhood: a new challenge.
- Published in:
- Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1569972
- By:
- Publication type:
- Article
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom.
- Published in:
- Journal of Gastroenterology, 2025, v. 60, n. 3, p. 389, doi. 10.1007/s00535-025-02214-2
- By:
- Publication type:
- Article
Effects of Acupuncture on the mRNA Expression of NF-κB p65/TNF-α Activated by Fat Accumulation in High-fat Diet-induced Nonalcoholic Fatty Liver Disease Rats.
- Published in:
- Indian Journal of Animal Research, 2025, v. 59, n. 2, p. 281, doi. 10.18805/IJAR.BF-1815
- By:
- Publication type:
- Article
Protocatechuic Acid Protects Mice Against Non-Alcoholic Fatty Liver Disease by Attenuating Oxidative Stress and Improving Lipid Profile.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2024, v. 13, n. 2, p. 218, doi. 10.61186/rbmb.13.2.218
- By:
- Publication type:
- Article
Metformin Attenuates Hepatic Fibrosis in Mice by Altering the Gut Microbiota.
- Published in:
- Hepatitis Monthly, 2024, v. 24, n. 1, p. 1, doi. 10.5812/hepatmon-149965
- By:
- Publication type:
- Article
Laparoscopic Roux-en-Y Versus Mini-Gastric Bypass on Liver Function at 6 Months in Morbid Obesity Patients: A Cross-Sectional Study.
- Published in:
- Hepatitis Monthly, 2024, v. 24, n. 1, p. 1, doi. 10.5812/hepatmon-141884
- By:
- Publication type:
- Article
Biochemical screen correction possibilities in patients with non-alcoholic fatty liver disease with diabetes mellitus.
- Published in:
- Regulatory Mechanisms in Biosystems, 2018, v. 9, n. 3, p. 384, doi. 10.15421/021857
- By:
- Publication type:
- Article
Andrographolide Inhibits the NF-κB Signaling Pathway and Alleviates High-Fat Diet-Induced Hepatic Inflammation in a Mouse Model of Nonalcoholic Fatty Liver Disease.
- Published in:
- Natural Product Communications, 2025, v. 20, n. 2, p. 1, doi. 10.1177/1934578X241302020
- By:
- Publication type:
- Article
Non-invasive hepatic fat quantification: Can multi-echo Dixon help?
- Published in:
- Radiologia Brasileira, 2024, v. 57, p. 1, doi. 10.1590/0100-3984.2023.0125
- By:
- Publication type:
- Article
Quantificação da gordura hepática: avaliação de diferentes estratégias de medidas pela ressonância magnética nos casos de distribuição homogênea e heterogênea.
- Published in:
- Radiologia Brasileira, 2024, v. 57, p. 1, doi. 10.1590/0100-3984.2024.0009
- By:
- Publication type:
- Article
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?
- Published in:
- Cell Biochemistry & Biophysics, 2025, v. 83, n. 1, p. 279, doi. 10.1007/s12013-024-01555-8
- By:
- Publication type:
- Article